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Inhibition of Kidney IVIitochondrial
IVIonoamine Oxidase Activity by the
Nephrosis-Producing Aminonucleoside
of Puromycin
Paul Bartlett, PhD; Mei-hwa Tu, MS, and Kathleen Ashworth, MS

Intraperitoneal administration in rats of a single large injection of the potent nephrotogenic aminonucleoside.6-dimethylamino-9-(3'-amino-3' =^deoxy-/J-D-ribofuranosyl)purine, resulted in striking reductions in kidney cortex mitochondrial monoamine oxidase (MAO) activity, assayed on tyramine substrate The alterations in enzymatic activity
correlated remarkably well with the onset and development of the massive proteinuria
characteristic of the disease. The inhibitory effects were also produced iVi vitro, and
Lineweaver-Burk reciprocal plots were clearly indicative of non-competitive inhibition.
It is suggested that aminonucleoside inhibition of kidney mitochondrial MAO activity
may be a biochemical lesion in the primary step of GBM collagen cross-link formation,
whereby collagen fibrillogenesis is impaired and semipermeability of the GBM to macromolecular plasma proteins altered. Observation of relatively high concentrations of
5-hydroxytryptamine in aminonucleoside-nephrotic rat kidneys suggests significant
impairment of serotonin, and probably also catecholamine, metabolism in the diseased
kidneys.

Ofthe many explanations proposed for
the semipermeability characteristics and
filter-like function of the glomerular basement membrane (GBM). the concept that
the membrane has a gel-like structure, in
which fine fibrillar-like components arc
embedded in the amorphous matrix'
forming a filtering membrane, seems most
acceptable. Such a structure, particularly
if it behaves as a thixotropic gel.'^ would
permit the passage of particles of all sizes
without deformation of the membrane.
Now while fibrillar-like components are
seen in fi.xed sections of GBM subjected
to electron microscopy, these probably
reflect only a transient state in an ongoing interaction belween the collagen-
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glycoprotein componenis in the membrane matrix.' At a given point in lime
one might certainly expect the flux of
protein molecules to be affected by a variety of parameters known to influence gel
formation. Factors affecting the degree of
hydration ofthe gel, the concentration or
ionic strength of electrolytes in the gel —
and certainly in the case of GBM collagen — the extent and nature of intraand inter-molecular cross-linkages
involved in fibrillogenesis must, for
example, be considered as affecting,
either singularly or in combination, the
semipermeability characteristics of such
membranes. In this context, the possibility of the existence of a biochemical
lesion in the primary step in collagen
cross-link formation, whereby collagen
fibrillogenesis becomes impaired and
semipermeability of the GBM altered,
seemed worthy of investigation.
In several tissues, the initial step in the
formation of collagen cross-links involves
oxidative deamination of the e-amino
group of certain pcptidc-bound lysyl
residues in the collagen polypeptide
chains, resulting in the formation of Asemialdehydes or allysyl residues.^'"
These then spontaneously either crosslink by aldol condensation with another
similarly deaminated lysyl residue in
another peptide chain, or form an aklimine criiss-link by Schiff base formation
with an €-amino group of another lysine
resuliie ' Sludies from several dilTerent
laboratories on the mechanism of action
of Ihe lathyrogenic /i-aminopropionitrile
(/3-APN) .ind copper deficiency on crosslinking of collagen and elastin have
clearly demonstrated that an amine oxid.iscil ( I 4 1 4 ) IS inu>l\cil III the initial
oxid.ilive deamination step.''"''
I he pieseni communication specifie.illy relates to monoamine oxidase
I M AO) activity in mitochondria isolated
from kidney cortex of normal rats and
fiom simil.ir groups of rats treated with

the
nephrosis-producing
aminonucn
leoside. 6-dimethylamino - 9 - (3' - amir
- 3' - deoxy - f3 - D - ribofuranosyl) I
purine. Results of ancillary studies rela;
ing to the mechanism of action of theP
aminonucleoside are also reported.

Methods
Aminonucleoside nephrosis may bt
induced in Sprague-Dawley (150-200g
rats either by a single intraperitonea
injection of 15 mg of the compound Unsolved in 1 ml of isotonic saline orb;
daily injection (subcutaneously) of 15 m;
of the compound per 100 g body wci^l
per day for a period of 10 days. In ciihc
case proteinuria commences on or
the fifth to sixth day after adminisiiatiof
ofthe aminonucleoside. Terminally, le.othe 10th day of the induction period. ur>
nary excretion of protein ranges fror
200-595 mg/24 hr collection period.
Both normal and aminonuclcosk!.
treated rats were fasted for 24 hours prio
to sacrifice by stunning and ew
guination. The kidneys were immedi.iic
excised, decapsulated, and the coriia
processed for subcellular fractions
described by Shibko and Tappel." Th
procedure, although originally designe.
for the isolation of lysosomal fraction*
provides pellets and supernatants uhi.
can be further processed for mitochtw
dria. microsomes, and cytoplasmic super
natants.
Monoamine oxidase (MAO) activii)
was measured by the fluorometric proc^
dure described by Tipton,'" usifr
tyramine substrate. A standard curve i'the production of hydrogen peroxide le^
pressed in nanomoles, nM) ^ f f "
fluorescence units (expressed in
roamperes) was prepared for each senf"
of assays. Mitochondria equivalent'
four dilTerent concentrations of mitoch^'
drial protein were used in each M'^
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TABLE 1.
Effects of the Aminonucleoside of Puromycin on
Rat Kidney Cortex Mitochondrial Monoamine Oxidase Activity
IVIonoamine oxidase activityt

No.

Day of
experiment*

Urine
protein+

I
li
III
IV
V

4
6
8
10
10

35 (17-52)
123 (83-167)
359 (300-425)
398 (131-680)
398 (131-680)

Experiment

Normal
rat

mg/24 hr

Treated
rat

nM H:Oj/min/mg protein
1 00
0.95
097
0.60
1.10
080
086
0.51
1 02
0 57

In vitro Experiment
VI a. Normal Assay

1.10
0.81

b. Same as a plus aminonucleoside (1.35 x 10 "M)
'Days ,ii!er injection ol treated rats with a single 15 mg dose of aminonucleoside dissolved in

1 ml isotonic salme.
Mean .md range of excretion for rats in treated group Normal rats averaged 7 mg,'24 hr; with a
range o! 2-24 mg/24 hr
:Monoamine oxidase activity determined as described by T i p t o n , " in mitochondria isolated from the pooled
Sidney corlex of 3 rats p>er experiment

The slopes of linear plots of H-Oa,
produced (nM/min/mg protein) at the four
Jifferent levels of mitochondrial protein.
\^ere taken as a measure of the enzyme
-u\i\\ Protein was determined in Ihe
nous fractions by the Miller modIrfication'" of the Lowry assay.'"

oxidase! MAO) activity was determined
in mitochondria isolated from kidney cortex from normal untreated rats and fiom
similar groups of rats sacrificed at various
times after adminisiraiion of the
nephrotogenic aminonucleoside of
puromycin. Even as early as four days af
ter injection of the single large dose of
aminonucleoside. and correlating remarkably well with the first indication of
increased protein excretion, a slight
reduction in MAO activity appears to
have been induced. Striking reductions
were seen at six. eight and ten days
post injection.

Results and Discussion
Preliminary studies conducted in our
laboratory for the purpose of ascertaining
- Jistribution of M.AO activity in nor'^''1 rat kidney cortex revealed the
Mitochondrial fraction to be clearly the
I Host active. Specific activities of kidney
i-'x homogenate. mitochondrial.
^K^osomal and lysosomal fractions were
i'e'>Pectively. 0.30. 0.55. 0.10 and 0.03 nM
[^-Oj min/mg protein. All subsequent
i^'udies were conducted on mitochondria.

The sixth experiment was an in vilro
one. in which milochiindria from normal
rat kidney cortex were incubated in the
absence of aminonuclei>side and with 1.36
X 10"^ M aminonucleoside added during
the 10 minute assay period. Presence of
the aminonucleoside produced a striking
inhibition of MAO activity (about 26',^).

^^hle I summarizes the results of
••".ll cxpcrinienis in uhieh mono.miiiie
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4

_L
V

3NOR\WL KIDNEY MITOCHONDRIA
& AMINONUCLEOSIDE
2 X 10"" M

NORMAL
KIDNEY MITOCHONORW

= 1.65X lO'^M

(1/S) X 10'M

Figure 1
Kinetics of inhibition of kidney mitochondrial monoamine oxida.se (MAO) activity by aminonucleosidt.
A.ssay conditions des<-rit>ed in Methods. Abscissa gives the reciprocal of Ihe molarity of tyramine. ant
th* ordinate gives Ihe reciprocal of Ihe production of H.O; in nM/min/mg protein.

Some msiuht into the mechanism ofthe
inhibitory effects of aminonucleoside on
kidney mitochondrial MAO activity is
pioMded by the l.incweaver-Burk lecipri>cal plot shown in Figure 1. In the presence and absence of 2 x 10"^ M
aminonucleoside. the l/V versus l/S plots
intersect on the baseline—clearly indicating a purely non-competitive inhibition.
From the baseline intersection, a Km
value of 1.65 x 10'* M was calculated.
From the points of intersection of the
ieciproc.il plots with the vertical axis and
the inhibitor concentration, the Ki value
was calculated to be 5.88 x \0 *. By the
Oixon graphical procedure, a K j value of

5.35 x 10'* was obtained directly from the
plot of l/V versus i .
The fact that aminonucleoside has no
demonstrable in vitro effect on the
pcroxidase-stimulated second step of th*
coupled reaction involved in the Tir'''
M.AO assay, focuses attention on the im
tial MAO-catalyzed step in which ih^
tyramine substrate is oxidized to an
aldehyde, ammonia and hydroge"
peroxide. .Acting non-competitivel\. i^"
aminonucleoside does not affect ihf
combination of the substrate with thf
enzyme, but affects only the velociiv
the reaction. While this mighi
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explained by failure of the enzymeinhibitor-substrate complex to break
down (equivalent to an effective reduction in the concentration of active
enzyme), it might also be due to actual
breakdown of this complex at a velocit\
less inan that of the enzyme substrate,
the ne! effect of which would be a reduction in the measured rate of H.-O- production.

aminonucleoside-treated rats. Doubtfiil
correlation ofthe time-course of development of such alterations with the initiation and onset of massive proteinuria,
however, cautions against acceptance of
tubular defects as adequatel\ explaining
the pathogenesis of the proteinuria.
However, of even greater significance
in the development of the renal dise.ise
than the hypothesized effects of aminonucleoside on collagen cross-linking
and fibrillogenesis in GBM and tubular
cell basement membranes may be the
inhibition of the enzymatic activity
involved in the oxidative deamination of
cellular
5-hydroxytryptamine
(serotonin). In this context several observations are of interest. Oliver and coworkers'--, for example, have reported
increased
urinary excretion of
catecholamines by edematous nephrotic
children, and Boiges and Bessman'-'' have
reported a large reduction in the excretion of 5-hydroxyindole acetic acid, a
major product of serotonin metabolism,
by patients with glomerular nephritis
Accumulation of 5-hydroxytryptamine
might thus be expected in kidneys of
aminonucleoside-nephrotic rals. and
indeed exploratory studies conducted in
our laboratory confirm this speculation.
Thus, a relatively high concentration of 5hydroxytryptamine (ie. 2.65± 1.09 ngm/g
tissue) in the kidneys of rats treated vvith
a series of ten small daily injections of
aminonucleoside. in comparison with a
value of 1.48±0.21 ngm/g tissue in the kidneys of six normal untreated rats, might
be
attributed
to
aminonucleosideinhibition of MAO activity. Of more than
passing interest also are the results of
studies on the nephrotoxicity of 5hydroxylryplamine in the rat.-* Tubular
effects of this substance^* and those
recently reported for the aminonucleoside
of puromycin*' are strikingly similar, ie.
necrosis of the proximal convoluted
tubule and tubular dilatation. The timecourse of occurrence of such changes, ie.

In final analysis, determination of the
:elc\. ice of the present observations on
(he inhibitory effects of aminonucleoside
on \ l \ 0 activity in kidney mitochondria
10 the cross-linking mechanism in GBM
collagen, must await conclusive demon>tration that the \ \ . \ 0 activity assayed
on tyramine substrate is indeed the
enzymatic activity involved in converting
collagen peptide-bound lysyl residues to
allysyl residues and that these subsequently, by aldol or aldimine condensation, form the collagen cross-links.
Promise of forth-coming purification
procedures for an approximately 500-fold
purified specific lysyl oxidase enzyme by
DE.\E-cellulose chromatography
should facilitate in-depth studies of the
working hypothesis proposed herein.
Now while the foregoing has focused
attention on the relationship of inhibited
MAO activity to the process of crosslinking and fibrillogenesis in GBM collagen, the relationship of inhibited MAO
'n tubule cell mitochondria to altered
cross-linking and fibrillogenesis in proxi"lal tubule cell basement membrane collagen should also be examined. Certainly
proximal tubule cell mitochondria con'ribute significantly to the isolated kidney
'•'oriex mitochondrial population in which
MAO activity is inhibited by aminonuc''oside. In this context recently published
^«^ults of a study of renal tubular effects
''f'he aminonucleoside of puromycin-'
provide some support for the view that a
'^^fect in proximal tubular reabsorption of
Protein may explain the proteinuria of
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subsequent to the onset of proteinuria,
would however seem to place these
effects in the category of secondary
rather than primary effects of aminonucleoside: and as such they can not be considered as causally related to the initiation and onset of the proteinuria charac-

teristic of the nephrotic syndromt
Tubular reabsorption of protein might l<
expected to be reduced in neciotic
tubules, however, and may be of sif
ficient magnitude to contribute s cantly to the massive proteinuria cf th;
aminonucleoside-induced nephropathy.
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